TNXP | Woo Trader

BTNXP - Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp. is a specialty pharmaceutical company focused on developing new pharmaceutical products for CNS conditions. The Company develops therapies for disorders that include fibromyalgia syndrome and post-traumatic stress disorder. Its lead product candidates include TNX-102, for the management of fibromyalgia syndrome and TNX-105 to treat symptoms of post-traumatic stress disorder. Tonix Pharmaceuticals Holding Corp. is headquartered in New York.

Last Close	$2.97^-1.33%	Range	$2.91-$3.09
Volume	87,600^-17%	Market Cap	$18.76 M
Avg Daily $	$314,992	Avg Volume	106,058
52 Week High	$9.40^-68%	52 Week Low	$0.33^+800%
Insider Score	No Activity	%Insiders	4%
%Institutions	25.24%	%M.F.	2.18%
Price Target	N/A	Mean Rating	Perform
Zacks Target	$10.00^+237%	Zacks Rating	Hold
TR Target	$10.00^+237%	TR Rating	Buy
News/Blogs	N/A	With Impact	N/A
Next Earnings	2017-11-09	Forward EPS	‑$0.70
EPS	-4.95	P/E	-0.6
Dividend	N/A	Yield	N/A

Wootrader.com is moving to https://financeboards.com - sign up for a free account.

BTNXP - Tonix Pharmaceuticals Holding Corp.

This full content is available for membership level Budding Investor or higher. You can register for a new account now.